Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors

• Martina Zimmermann,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany

  ⨯
• Sorin Armeanu-Ebinger,

  Affiliation University Childrens Hospital, Tübingen, Germany

  ⨯
• Sascha Bossow,

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯
• Johanna Lampe,

  Affiliation Institute for Molecular Medicine Finland FIMM, Helsinki, Finland

  ⨯
• Irina Smirnow,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany

  ⨯
• Andrea Schenk,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany

  ⨯
• Sebastian Lange,

  Affiliation Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, München, Germany

  ⨯
• Thomas S. Weiss,

  Affiliation Center for Liver Cell Research, Department of Pediatrics and Adolescent Medicine, University of Regensburg Hospital, Regensburg, Germany

  ⨯
• Wolfgang Neubert,

  Affiliation Max-Planck-Institute for Biochemistry, Department Molecular Virology, Martinsried Germany

  ⨯
• Ulrich M. Lauer,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany

  ⨯
• Michael Bitzer

  * E-mail: michael.bitzer@uni-tuebingen.de

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany

  ⨯